{"gene":"NRN1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2023,"finding":"NRN1 (neuritin) provides dendritic spine resilience against amyloid-β (Aβ) and blocks Aβ-induced neuronal hyperexcitability in cultured neurons, acting as a hub protein in a synaptic biology module. Exogenous NRN1 alters the neuronal proteome in ways that overlap with human AD brain resilience pathways.","method":"Microscopy, electrophysiology in cultured neurons, TMT-MS proteomics, weighted gene correlation network analysis","journal":"Molecular & cellular proteomics : MCP","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (imaging, physiology, proteomics) in a single lab","pmids":["37024090"],"is_preprint":false},{"year":2021,"finding":"NRN1 suppresses esophageal cancer cell proliferation, migration, invasion, and induces apoptosis and G1/S arrest by inhibiting PI3K-Akt-mTOR signaling. NRN1 expression is silenced by promoter methylation, and its loss renders cells synthetically lethal to combined PI3K and ATR inhibition.","method":"siRNA knockdown, flow cytometry, colony formation assay, xenograft mouse model, methylation-specific PCR","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with defined cellular phenotype, in vivo validation, single lab","pmids":["33931924"],"is_preprint":false},{"year":2019,"finding":"miR-194 directly targets NRN1 and suppresses its expression; reduced NRN1 leads to decreased PI3K/Akt signaling, reduced Bcl-2, increased Bax/Caspase-3, and accelerated apoptosis of Aβ1-42-transduced hippocampal neurons, while NRN1 overexpression is neuroprotective.","method":"miRNA mimic transfection, NRN1 overexpression lentiviral vectors, Western blot, MTT assay, immunofluorescence for neurite length, flow cytometry","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 2 — target validation by reciprocal gain/loss-of-function with multiple readouts, single lab","pmids":["31010100"],"is_preprint":false},{"year":2020,"finding":"Nrn1 overexpression in retinal ganglion cells (via intravitreal AAV2-Nrn1) activates Akt1 and Stat3 signaling pathways and inhibits the mitochondrial apoptotic pathway, resulting in reduced RGC apoptosis and promotion of optic nerve axon regeneration following optic nerve crush.","method":"rAAV2-mediated overexpression, immunoblot for Akt1/Stat3/apoptotic pathway proteins, retinal imaging, histopathology, in vivo physiological function assays","journal":"Journal of molecular neuroscience : MN","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo functional assay with pathway-level mechanistic follow-up, single lab","pmids":["32607759"],"is_preprint":false},{"year":2020,"finding":"HIF1α binds functional response elements in the NRN1 promoter and drives NRN1 transcription under hypoxic conditions in testicular germ cell tumor cells; HIF1α inhibition or siRNA knockdown of either HIF1α or NRN1 suppresses PDC spheroid growth in vitro and in vivo.","method":"Promoter activity analysis (HIF1α response elements), siRNA knockdown, HIF1α inhibitor (2-methoxyestradiol), PDC spheroid cultures, xenograft models","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — promoter functional analysis plus epistatic in vivo validation, single lab","pmids":["32544513"],"is_preprint":false},{"year":2024,"finding":"NRN1 directly interacts with the cleaved intracellular domain (NICD) of Notch1 and Notch3 in melanoma cells, causing potential cytoplasmic retention of NICD and reduced expression of Hes1. This decreases Hes1-driven JAK/STAT3 sequestration, leading to reduced STAT3 phosphorylation but increased total STAT3 levels, and upregulation of oncogenic STAT3 targets (VegfA, Mdr1, cMet).","method":"Kinase phosphorylation kit, promoter activity analysis, co-immunoprecipitation/interaction analysis, real-time cell analysis, spheroid formation, mRNA and protein analysis","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct interaction shown and downstream pathway mechanistically traced, single lab","pmids":["38705997"],"is_preprint":false},{"year":2021,"finding":"NRN1 promotes cell viability in clear cell renal cell carcinoma and upregulates CXCR4; NRN1 knockdown by siRNA suppresses RCC-PDC xenograft tumor proliferation and represses CXCR4 expression in vivo.","method":"Gain- and loss-of-function (siRNA/overexpression) in PDC spheroids, xenograft tumor model, RNA-sequencing dataset correlation analysis","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 3 — single lab, correlation-based target identification, functional validation in vivo but limited mechanistic depth","pmids":["34804954"],"is_preprint":false},{"year":2024,"finding":"NEFL (neurofilament light chain) regulates NRN1 expression, and NRN1 in turn mediates the mitochondrial apoptotic pathway (affecting ROS accumulation, mitochondrial membrane potential, and morphology) in diacetylmorphine-induced neuronal apoptosis; overexpression or silencing of NEFL alters NRN1 levels and downstream mitochondrial changes.","method":"TMT proteomics, lentiviral overexpression/silencing, transmission electron microscopy, ROS measurement, mitochondrial membrane potential assay","journal":"Molecular neurobiology","confidence":"Low","confidence_rationale":"Tier 3 — single lab, mechanistic pathway partly inferred, limited direct NRN1 assay","pmids":["39557800"],"is_preprint":false},{"year":2025,"finding":"NRN1 reduces tau hyperphosphorylation (p-tau) and neuronal apoptosis in AD cell models by modulating the PIGU-CASP3 pathway; NRN1 also increases MAP2 expression and the Bcl-2/Bax ratio, and decreases cleaved caspase-3.","method":"Western blot in AD cell models, bioinformatics (correlation analysis, GO/KEGG, PPI network), in vivo hippocampal analysis in AD mice","journal":"Current Alzheimer research","confidence":"Low","confidence_rationale":"Tier 3 — mechanistic pathway largely inferred by bioinformatics, modest in vitro/in vivo validation, single lab","pmids":["40296620"],"is_preprint":false},{"year":2026,"finding":"NRN1 protein forms a homodimer (detected at molecular weights consistent with dimerization by Western blot in rodents, humans, and cell models); NRN1 protein abundance decreases in excitatory neurons with AD progression (single-nucleus RNA sequencing data).","method":"Western blot with densitometry, single-nucleus RNA sequencing (SEA-AD atlas)","journal":"Alzheimer's & dementia","confidence":"Low","confidence_rationale":"Tier 3 — homodimerization inferred from molecular weight shift on Western blot, single lab, not directly validated by reconstitution or structural methods","pmids":["41645874"],"is_preprint":false}],"current_model":"NRN1 (neuritin-1) is a GPI-anchored neurotrophic factor that promotes dendritic spine stability and axonal/dendritic growth, protects neurons from apoptosis via Akt1/Stat3 activation and mitochondrial pathway inhibition, is transcriptionally driven by HIF1α, is targeted (suppressed) by miR-194, directly interacts with Notch1/3 intracellular domains to modulate STAT3 signaling in cancer, and inhibits PI3K-Akt-mTOR signaling to suppress tumor cell proliferation — with its expression regulated epigenetically by promoter methylation and by BDNF-dependent mechanisms."},"narrative":{"teleology":[{"year":2019,"claim":"Establishing that NRN1 is a direct target of miR-194 and that its expression level determines neuronal survival versus apoptosis via PI3K/Akt and mitochondrial pathways in Aβ-challenged hippocampal neurons answered how NRN1 is post-transcriptionally regulated and linked it mechanistically to anti-apoptotic signaling.","evidence":"miR-194 mimic transfection and NRN1 lentiviral overexpression in Aβ1-42-treated hippocampal neurons with Western blot, flow cytometry, and neurite length analysis","pmids":["31010100"],"confidence":"Medium","gaps":["Direct miR-194–NRN1 3′UTR binding validated only by reporter; endogenous stoichiometry in vivo unknown","Upstream regulators of miR-194 in AD context not identified"]},{"year":2020,"claim":"Demonstrating that NRN1 overexpression in retinal ganglion cells activates Akt1/Stat3 and blocks the mitochondrial apoptotic cascade to promote axon regeneration after optic nerve crush established NRN1 as a bona fide pro-survival and pro-regenerative factor in the adult CNS in vivo.","evidence":"AAV2-mediated NRN1 overexpression in a rat optic nerve crush model with immunoblot and histopathological analysis","pmids":["32607759"],"confidence":"Medium","gaps":["Receptor or binding partner mediating Akt1/Stat3 activation by NRN1 not identified","Whether the GPI anchor is required for signaling was not tested"]},{"year":2020,"claim":"Identifying HIF1α-responsive elements in the NRN1 promoter and showing epistatic dependence of tumor spheroid growth on HIF1α-driven NRN1 expression revealed how NRN1 is transcriptionally activated under hypoxia in cancer.","evidence":"Promoter–reporter assays, HIF1α siRNA/inhibitor treatment in testicular germ cell tumor PDC spheroids and xenografts","pmids":["32544513"],"confidence":"Medium","gaps":["Whether HIF1α regulation of NRN1 operates in hypoxic neurons was not examined","Other transcription factors contributing to NRN1 induction under hypoxia remain uncharacterized"]},{"year":2021,"claim":"Showing that NRN1 re-expression suppresses esophageal cancer proliferation and invasion by inhibiting PI3K-Akt-mTOR signaling — and that NRN1 is silenced by promoter methylation — established NRN1 as an epigenetically regulated tumor suppressor in this context.","evidence":"siRNA knockdown, methylation-specific PCR, colony formation, flow cytometry, xenograft in esophageal cancer cells","pmids":["33931924"],"confidence":"Medium","gaps":["Mechanism by which a GPI-anchored protein inhibits intracellular PI3K-Akt-mTOR signaling not resolved","Whether methylation-mediated silencing occurs broadly across cancer types is unclear"]},{"year":2023,"claim":"Demonstrating that exogenous NRN1 stabilizes dendritic spines against Aβ oligomers and suppresses neuronal hyperexcitability, with proteomic overlap to human AD resilience modules, positioned NRN1 as a synaptic resilience factor in Alzheimer's disease.","evidence":"Microscopy, electrophysiology, TMT-MS proteomics, and WGCNA in cultured neurons treated with Aβ and NRN1","pmids":["37024090"],"confidence":"Medium","gaps":["In vivo validation of NRN1-mediated synaptic resilience in AD mouse models not performed in this study","Direct receptor or co-receptor for exogenous NRN1 at the synapse remains unknown"]},{"year":2024,"claim":"Identifying a direct physical interaction between NRN1 and the intracellular domains of Notch1/3, with consequent cytoplasmic retention of NICD and remodeling of STAT3 signaling, provided the first defined binding partner through which NRN1 modulates an oncogenic signaling cascade.","evidence":"Co-immunoprecipitation, promoter activity analysis, phospho-kinase arrays, real-time cell analysis, and spheroid assays in melanoma cells","pmids":["38705997"],"confidence":"Medium","gaps":["Structural basis of NRN1–NICD interaction not determined","Whether NRN1–Notch interaction occurs in neurons or other non-cancer contexts is untested","Single co-IP study; reciprocal endogenous validation in independent labs needed"]},{"year":2025,"claim":"Evidence that NRN1 reduces tau hyperphosphorylation and caspase-3 cleavage via the PIGU-CASP3 axis extended NRN1's neuroprotective role beyond Aβ toxicity to tau pathology.","evidence":"Western blot in AD cell models, bioinformatic pathway inference, hippocampal analysis in AD mice","pmids":["40296620"],"confidence":"Low","gaps":["PIGU–CASP3 pathway link to NRN1 is largely bioinformatically inferred and not reconstituted","Direct physical interaction between NRN1 and PIGU not demonstrated","Single lab with modest validation"]},{"year":2026,"claim":"Detection of NRN1 homodimers by molecular weight shift on Western blot, together with decreased NRN1 expression in excitatory neurons during AD progression, suggested a previously unrecognized oligomeric state relevant to disease.","evidence":"Western blot with densitometry in rodent and human samples; single-nucleus RNA sequencing from the SEA-AD atlas","pmids":["41645874"],"confidence":"Low","gaps":["Homodimerization inferred solely from molecular weight; no crosslinking, analytical ultracentrifugation, or structural validation","Functional significance of dimerization not tested","Transcriptomic decrease does not confirm protein-level loss at the synapse"]},{"year":null,"claim":"The identity of the cell-surface receptor or co-receptor through which extracellular/GPI-anchored NRN1 activates intracellular Akt, STAT3, and PI3K signaling remains unknown, and structural information on NRN1 — including the basis of any homodimerization — is lacking.","evidence":"","pmids":[],"confidence":"High","gaps":["No receptor identified for NRN1 signaling on target cells","No crystal or cryo-EM structure available","Mechanism of GPI-anchored protein influencing intracellular kinase cascades is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,3,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,5]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,3,5]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2,3]}],"complexes":[],"partners":["NOTCH1","NOTCH3","HIF1A","NEFL"],"other_free_text":[]},"mechanistic_narrative":"NRN1 (neuritin-1) is a GPI-anchored neurotrophic factor that promotes neuronal survival, neurite outgrowth, and dendritic spine stability, while also modulating tumor cell behavior through multiple signaling axes. In neurons, NRN1 activates Akt1 and Stat3 signaling and inhibits the mitochondrial apoptotic pathway (reducing Bax/caspase-3, increasing Bcl-2), conferring protection against amyloid-β toxicity, optic nerve injury, and tau hyperphosphorylation [PMID:32607759, PMID:31010100, PMID:37024090, PMID:40296620]. NRN1 transcription is driven by HIF1α under hypoxia and silenced by promoter methylation, and NRN1 is post-transcriptionally suppressed by miR-194 [PMID:32544513, PMID:33931924, PMID:31010100]. In cancer cells, NRN1 directly interacts with the intracellular domains of Notch1 and Notch3 to modulate STAT3 signaling in melanoma, and its re-expression in esophageal cancer suppresses proliferation by inhibiting PI3K-Akt-mTOR signaling [PMID:38705997, PMID:33931924]."},"prefetch_data":{"uniprot":{"accession":"Q9NPD7","full_name":"Neuritin","aliases":[],"length_aa":142,"mass_kda":15.3,"function":"Promotes neurite outgrowth and especially branching of neuritic processes in primary hippocampal and cortical cells","subcellular_location":"Cell membrane; Synapse","url":"https://www.uniprot.org/uniprotkb/Q9NPD7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NRN1","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NRN1","total_profiled":1310},"omim":[{"mim_id":"612582","title":"CHROMOSOME 6pter-p24 DELETION SYNDROME","url":"https://www.omim.org/entry/612582"},{"mim_id":"607409","title":"NEURITIN 1; NRN1","url":"https://www.omim.org/entry/607409"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":187.2}],"url":"https://www.proteinatlas.org/search/NRN1"},"hgnc":{"alias_symbol":["NRN"],"prev_symbol":[]},"alphafold":{"accession":"Q9NPD7","domains":[{"cath_id":"-","chopping":"31-115","consensus_level":"high","plddt":82.8138,"start":31,"end":115}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPD7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPD7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPD7-F1-predicted_aligned_error_v6.png","plddt_mean":78.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NRN1","jax_strain_url":"https://www.jax.org/strain/search?query=NRN1"},"sequence":{"accession":"Q9NPD7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NPD7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NPD7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPD7"}},"corpus_meta":[{"pmid":"37024090","id":"PMC_37024090","title":"Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease.","date":"2023","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/37024090","citation_count":51,"is_preprint":false},{"pmid":"33931924","id":"PMC_33931924","title":"Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33931924","citation_count":30,"is_preprint":false},{"pmid":"19569075","id":"PMC_19569075","title":"Impact of Neuritin 1 (NRN1) polymorphisms on fluid intelligence in schizophrenia.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19569075","citation_count":27,"is_preprint":false},{"pmid":"31176712","id":"PMC_31176712","title":"Association of AEBP1 and NRN1 RNA expression with Alzheimer's disease and neurofibrillary tangle density in middle temporal gyrus.","date":"2019","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31176712","citation_count":22,"is_preprint":false},{"pmid":"26700405","id":"PMC_26700405","title":"Involvement of NRN1 gene in schizophrenia-spectrum and bipolar disorders and its impact on age at onset and cognitive functioning.","date":"2015","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26700405","citation_count":19,"is_preprint":false},{"pmid":"32285140","id":"PMC_32285140","title":"The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.","date":"2020","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/32285140","citation_count":18,"is_preprint":false},{"pmid":"31010100","id":"PMC_31010100","title":"miR-194 Accelerates Apoptosis of Aβ1⁻42-Transduced Hippocampal Neurons by Inhibiting Nrn1 and Decreasing PI3K/Akt Signaling Pathway Activity.","date":"2019","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/31010100","citation_count":15,"is_preprint":false},{"pmid":"32607759","id":"PMC_32607759","title":"Nrn1 Overexpression Attenuates Retinal Ganglion Cell Apoptosis, Promotes Axonal Regeneration, and Improves Visual Function Following Optic Nerve Crush in Rats.","date":"2020","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/32607759","citation_count":14,"is_preprint":false},{"pmid":"28107668","id":"PMC_28107668","title":"Neurotrophins role in depressive symptoms and executive function performance: Association analysis of NRN1 gene and its interaction with BDNF gene in a non-clinical sample.","date":"2016","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/28107668","citation_count":11,"is_preprint":false},{"pmid":"36765573","id":"PMC_36765573","title":"A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36765573","citation_count":10,"is_preprint":false},{"pmid":"32544513","id":"PMC_32544513","title":"HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroids.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32544513","citation_count":8,"is_preprint":false},{"pmid":"38705997","id":"PMC_38705997","title":"NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma.","date":"2024","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/38705997","citation_count":7,"is_preprint":false},{"pmid":"34530960","id":"PMC_34530960","title":"NRN1 and CAT Gene Polymorphisms, Complex Noise, and Lifestyles interactively Affect the Risk of Noise-induced Hearing Loss.","date":"2021","source":"Biomedical and environmental sciences : BES","url":"https://pubmed.ncbi.nlm.nih.gov/34530960","citation_count":6,"is_preprint":false},{"pmid":"35806464","id":"PMC_35806464","title":"NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35806464","citation_count":4,"is_preprint":false},{"pmid":"38720004","id":"PMC_38720004","title":"NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia.","date":"2024","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/38720004","citation_count":3,"is_preprint":false},{"pmid":"34804954","id":"PMC_34804954","title":"Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34804954","citation_count":2,"is_preprint":false},{"pmid":"39557800","id":"PMC_39557800","title":"NEFL Modulates NRN1-Mediated Mitochondrial Pathway to Promote Diacetylmorphine-Induced Neuronal Apoptosis.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39557800","citation_count":1,"is_preprint":false},{"pmid":"39426559","id":"PMC_39426559","title":"NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia.","date":"2024","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/39426559","citation_count":1,"is_preprint":false},{"pmid":"41645874","id":"PMC_41645874","title":"NRN1 as a therapeutic target for Alzheimer's disease.","date":"2026","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/41645874","citation_count":1,"is_preprint":false},{"pmid":"40296620","id":"PMC_40296620","title":"NRN1 may Modulate Tau Phosphorylation and Neuronal Apoptosis in AD via the PIGU-CASP3 Axis.","date":"2025","source":"Current Alzheimer research","url":"https://pubmed.ncbi.nlm.nih.gov/40296620","citation_count":0,"is_preprint":false},{"pmid":"36627356","id":"PMC_36627356","title":"NRN-EZ: an application to streamline biophysical modeling of synaptic integration using NEURON.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36627356","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.10.29.24315982","title":"CLOZAPINE-RELATED BRAIN<i>NRN1</i>EXPRESSION PATTERNS ARE ASSOCIATED WITH METHYLATION AND GENETIC VARIANTS IN SCHIZOPHRENIA","date":"2024-11-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.29.24315982","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.28.651013","title":"SAM-AMP lyases in CRISPR defence and anti-defence","date":"2025-04-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.28.651013","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.10.648218","title":"Inferring non-coding RNA regulatory network from transcriptomic data and curated databases","date":"2025-04-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.10.648218","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.18.623787","title":"<i>In silico</i> analysis of the evolution of root phenotypes during maize domestication in Neolithic soils of Tehuacán","date":"2024-11-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.18.623787","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15556,"output_tokens":2444,"usd":0.041664},"stage2":{"model":"claude-opus-4-6","input_tokens":5794,"output_tokens":2482,"usd":0.13653},"total_usd":0.178194,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2023,\n      \"finding\": \"NRN1 (neuritin) provides dendritic spine resilience against amyloid-β (Aβ) and blocks Aβ-induced neuronal hyperexcitability in cultured neurons, acting as a hub protein in a synaptic biology module. Exogenous NRN1 alters the neuronal proteome in ways that overlap with human AD brain resilience pathways.\",\n      \"method\": \"Microscopy, electrophysiology in cultured neurons, TMT-MS proteomics, weighted gene correlation network analysis\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (imaging, physiology, proteomics) in a single lab\",\n      \"pmids\": [\"37024090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NRN1 suppresses esophageal cancer cell proliferation, migration, invasion, and induces apoptosis and G1/S arrest by inhibiting PI3K-Akt-mTOR signaling. NRN1 expression is silenced by promoter methylation, and its loss renders cells synthetically lethal to combined PI3K and ATR inhibition.\",\n      \"method\": \"siRNA knockdown, flow cytometry, colony formation assay, xenograft mouse model, methylation-specific PCR\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular phenotype, in vivo validation, single lab\",\n      \"pmids\": [\"33931924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-194 directly targets NRN1 and suppresses its expression; reduced NRN1 leads to decreased PI3K/Akt signaling, reduced Bcl-2, increased Bax/Caspase-3, and accelerated apoptosis of Aβ1-42-transduced hippocampal neurons, while NRN1 overexpression is neuroprotective.\",\n      \"method\": \"miRNA mimic transfection, NRN1 overexpression lentiviral vectors, Western blot, MTT assay, immunofluorescence for neurite length, flow cytometry\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — target validation by reciprocal gain/loss-of-function with multiple readouts, single lab\",\n      \"pmids\": [\"31010100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nrn1 overexpression in retinal ganglion cells (via intravitreal AAV2-Nrn1) activates Akt1 and Stat3 signaling pathways and inhibits the mitochondrial apoptotic pathway, resulting in reduced RGC apoptosis and promotion of optic nerve axon regeneration following optic nerve crush.\",\n      \"method\": \"rAAV2-mediated overexpression, immunoblot for Akt1/Stat3/apoptotic pathway proteins, retinal imaging, histopathology, in vivo physiological function assays\",\n      \"journal\": \"Journal of molecular neuroscience : MN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional assay with pathway-level mechanistic follow-up, single lab\",\n      \"pmids\": [\"32607759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HIF1α binds functional response elements in the NRN1 promoter and drives NRN1 transcription under hypoxic conditions in testicular germ cell tumor cells; HIF1α inhibition or siRNA knockdown of either HIF1α or NRN1 suppresses PDC spheroid growth in vitro and in vivo.\",\n      \"method\": \"Promoter activity analysis (HIF1α response elements), siRNA knockdown, HIF1α inhibitor (2-methoxyestradiol), PDC spheroid cultures, xenograft models\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional analysis plus epistatic in vivo validation, single lab\",\n      \"pmids\": [\"32544513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NRN1 directly interacts with the cleaved intracellular domain (NICD) of Notch1 and Notch3 in melanoma cells, causing potential cytoplasmic retention of NICD and reduced expression of Hes1. This decreases Hes1-driven JAK/STAT3 sequestration, leading to reduced STAT3 phosphorylation but increased total STAT3 levels, and upregulation of oncogenic STAT3 targets (VegfA, Mdr1, cMet).\",\n      \"method\": \"Kinase phosphorylation kit, promoter activity analysis, co-immunoprecipitation/interaction analysis, real-time cell analysis, spheroid formation, mRNA and protein analysis\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct interaction shown and downstream pathway mechanistically traced, single lab\",\n      \"pmids\": [\"38705997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NRN1 promotes cell viability in clear cell renal cell carcinoma and upregulates CXCR4; NRN1 knockdown by siRNA suppresses RCC-PDC xenograft tumor proliferation and represses CXCR4 expression in vivo.\",\n      \"method\": \"Gain- and loss-of-function (siRNA/overexpression) in PDC spheroids, xenograft tumor model, RNA-sequencing dataset correlation analysis\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, correlation-based target identification, functional validation in vivo but limited mechanistic depth\",\n      \"pmids\": [\"34804954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NEFL (neurofilament light chain) regulates NRN1 expression, and NRN1 in turn mediates the mitochondrial apoptotic pathway (affecting ROS accumulation, mitochondrial membrane potential, and morphology) in diacetylmorphine-induced neuronal apoptosis; overexpression or silencing of NEFL alters NRN1 levels and downstream mitochondrial changes.\",\n      \"method\": \"TMT proteomics, lentiviral overexpression/silencing, transmission electron microscopy, ROS measurement, mitochondrial membrane potential assay\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, mechanistic pathway partly inferred, limited direct NRN1 assay\",\n      \"pmids\": [\"39557800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NRN1 reduces tau hyperphosphorylation (p-tau) and neuronal apoptosis in AD cell models by modulating the PIGU-CASP3 pathway; NRN1 also increases MAP2 expression and the Bcl-2/Bax ratio, and decreases cleaved caspase-3.\",\n      \"method\": \"Western blot in AD cell models, bioinformatics (correlation analysis, GO/KEGG, PPI network), in vivo hippocampal analysis in AD mice\",\n      \"journal\": \"Current Alzheimer research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic pathway largely inferred by bioinformatics, modest in vitro/in vivo validation, single lab\",\n      \"pmids\": [\"40296620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NRN1 protein forms a homodimer (detected at molecular weights consistent with dimerization by Western blot in rodents, humans, and cell models); NRN1 protein abundance decreases in excitatory neurons with AD progression (single-nucleus RNA sequencing data).\",\n      \"method\": \"Western blot with densitometry, single-nucleus RNA sequencing (SEA-AD atlas)\",\n      \"journal\": \"Alzheimer's & dementia\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — homodimerization inferred from molecular weight shift on Western blot, single lab, not directly validated by reconstitution or structural methods\",\n      \"pmids\": [\"41645874\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NRN1 (neuritin-1) is a GPI-anchored neurotrophic factor that promotes dendritic spine stability and axonal/dendritic growth, protects neurons from apoptosis via Akt1/Stat3 activation and mitochondrial pathway inhibition, is transcriptionally driven by HIF1α, is targeted (suppressed) by miR-194, directly interacts with Notch1/3 intracellular domains to modulate STAT3 signaling in cancer, and inhibits PI3K-Akt-mTOR signaling to suppress tumor cell proliferation — with its expression regulated epigenetically by promoter methylation and by BDNF-dependent mechanisms.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NRN1 (neuritin-1) is a GPI-anchored neurotrophic factor that promotes neuronal survival, neurite outgrowth, and dendritic spine stability, while also modulating tumor cell behavior through multiple signaling axes. In neurons, NRN1 activates Akt1 and Stat3 signaling and inhibits the mitochondrial apoptotic pathway (reducing Bax/caspase-3, increasing Bcl-2), conferring protection against amyloid-β toxicity, optic nerve injury, and tau hyperphosphorylation [PMID:32607759, PMID:31010100, PMID:37024090, PMID:40296620]. NRN1 transcription is driven by HIF1α under hypoxia and silenced by promoter methylation, and NRN1 is post-transcriptionally suppressed by miR-194 [PMID:32544513, PMID:33931924, PMID:31010100]. In cancer cells, NRN1 directly interacts with the intracellular domains of Notch1 and Notch3 to modulate STAT3 signaling in melanoma, and its re-expression in esophageal cancer suppresses proliferation by inhibiting PI3K-Akt-mTOR signaling [PMID:38705997, PMID:33931924].\",\n  \"teleology\": [\n    {\n      \"year\": 2019,\n      \"claim\": \"Establishing that NRN1 is a direct target of miR-194 and that its expression level determines neuronal survival versus apoptosis via PI3K/Akt and mitochondrial pathways in Aβ-challenged hippocampal neurons answered how NRN1 is post-transcriptionally regulated and linked it mechanistically to anti-apoptotic signaling.\",\n      \"evidence\": \"miR-194 mimic transfection and NRN1 lentiviral overexpression in Aβ1-42-treated hippocampal neurons with Western blot, flow cytometry, and neurite length analysis\",\n      \"pmids\": [\"31010100\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct miR-194–NRN1 3′UTR binding validated only by reporter; endogenous stoichiometry in vivo unknown\", \"Upstream regulators of miR-194 in AD context not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that NRN1 overexpression in retinal ganglion cells activates Akt1/Stat3 and blocks the mitochondrial apoptotic cascade to promote axon regeneration after optic nerve crush established NRN1 as a bona fide pro-survival and pro-regenerative factor in the adult CNS in vivo.\",\n      \"evidence\": \"AAV2-mediated NRN1 overexpression in a rat optic nerve crush model with immunoblot and histopathological analysis\",\n      \"pmids\": [\"32607759\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor or binding partner mediating Akt1/Stat3 activation by NRN1 not identified\", \"Whether the GPI anchor is required for signaling was not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying HIF1α-responsive elements in the NRN1 promoter and showing epistatic dependence of tumor spheroid growth on HIF1α-driven NRN1 expression revealed how NRN1 is transcriptionally activated under hypoxia in cancer.\",\n      \"evidence\": \"Promoter–reporter assays, HIF1α siRNA/inhibitor treatment in testicular germ cell tumor PDC spheroids and xenografts\",\n      \"pmids\": [\"32544513\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HIF1α regulation of NRN1 operates in hypoxic neurons was not examined\", \"Other transcription factors contributing to NRN1 induction under hypoxia remain uncharacterized\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing that NRN1 re-expression suppresses esophageal cancer proliferation and invasion by inhibiting PI3K-Akt-mTOR signaling — and that NRN1 is silenced by promoter methylation — established NRN1 as an epigenetically regulated tumor suppressor in this context.\",\n      \"evidence\": \"siRNA knockdown, methylation-specific PCR, colony formation, flow cytometry, xenograft in esophageal cancer cells\",\n      \"pmids\": [\"33931924\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which a GPI-anchored protein inhibits intracellular PI3K-Akt-mTOR signaling not resolved\", \"Whether methylation-mediated silencing occurs broadly across cancer types is unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that exogenous NRN1 stabilizes dendritic spines against Aβ oligomers and suppresses neuronal hyperexcitability, with proteomic overlap to human AD resilience modules, positioned NRN1 as a synaptic resilience factor in Alzheimer's disease.\",\n      \"evidence\": \"Microscopy, electrophysiology, TMT-MS proteomics, and WGCNA in cultured neurons treated with Aβ and NRN1\",\n      \"pmids\": [\"37024090\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of NRN1-mediated synaptic resilience in AD mouse models not performed in this study\", \"Direct receptor or co-receptor for exogenous NRN1 at the synapse remains unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying a direct physical interaction between NRN1 and the intracellular domains of Notch1/3, with consequent cytoplasmic retention of NICD and remodeling of STAT3 signaling, provided the first defined binding partner through which NRN1 modulates an oncogenic signaling cascade.\",\n      \"evidence\": \"Co-immunoprecipitation, promoter activity analysis, phospho-kinase arrays, real-time cell analysis, and spheroid assays in melanoma cells\",\n      \"pmids\": [\"38705997\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of NRN1–NICD interaction not determined\", \"Whether NRN1–Notch interaction occurs in neurons or other non-cancer contexts is untested\", \"Single co-IP study; reciprocal endogenous validation in independent labs needed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Evidence that NRN1 reduces tau hyperphosphorylation and caspase-3 cleavage via the PIGU-CASP3 axis extended NRN1's neuroprotective role beyond Aβ toxicity to tau pathology.\",\n      \"evidence\": \"Western blot in AD cell models, bioinformatic pathway inference, hippocampal analysis in AD mice\",\n      \"pmids\": [\"40296620\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"PIGU–CASP3 pathway link to NRN1 is largely bioinformatically inferred and not reconstituted\", \"Direct physical interaction between NRN1 and PIGU not demonstrated\", \"Single lab with modest validation\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Detection of NRN1 homodimers by molecular weight shift on Western blot, together with decreased NRN1 expression in excitatory neurons during AD progression, suggested a previously unrecognized oligomeric state relevant to disease.\",\n      \"evidence\": \"Western blot with densitometry in rodent and human samples; single-nucleus RNA sequencing from the SEA-AD atlas\",\n      \"pmids\": [\"41645874\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Homodimerization inferred solely from molecular weight; no crosslinking, analytical ultracentrifugation, or structural validation\", \"Functional significance of dimerization not tested\", \"Transcriptomic decrease does not confirm protein-level loss at the synapse\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the cell-surface receptor or co-receptor through which extracellular/GPI-anchored NRN1 activates intracellular Akt, STAT3, and PI3K signaling remains unknown, and structural information on NRN1 — including the basis of any homodimerization — is lacking.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No receptor identified for NRN1 signaling on target cells\", \"No crystal or cryo-EM structure available\", \"Mechanism of GPI-anchored protein influencing intracellular kinase cascades is unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 5]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 3, 5]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NOTCH1\",\n      \"NOTCH3\",\n      \"HIF1A\",\n      \"NEFL\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}